GFAP and dementia: The findings that higher levels of GFAP and NfL were strongly associated with poorer cognitive functioning and an increased likelihood of dementia in both populations suggest that despite the differences in genetic background, environmental exposures, economic development, lifestyle factors, and healthcare systems between the two countries, these biomarkers are robust indicators of cognitive function and dementia.